March 17, 2026. 4 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score.
Sky News host James Macpherson looks at reports indicating medical cannabis does not …
Summary The article examines reports questioning cannabis efficacy for psychological conditions, relevant to clinicians evaluating evidence-based treatment applications across different patient populations.
Read more →Best THCa Flower Strains for Relaxation: 2026 – Weedmaps
This article reviews THCa flower strains marketed for relaxation, discussing terpene profiles like caryophyllene and their proposed interactions with the endocannabinoid system.
Read more →New Mexico Governor Quietly Approves Psychedelic Therapy Funds for Low-Income
Article Summary New Mexico Governor approves psychedelic therapy funding for low-income populations; tangentially relevant to cannabis clinicians monitoring broader psychoactive substance policy developments.
Read more →More details revealed on arrest of Alabama basketball star Aden Holloway: See the warrant
Summary Article reports police discovery of approximately 2 pounds of marijuana during arrest of college basketball player Aden Holloway, relevant to clinicians tracking cannabis-related legal cases involving athletes.
Read more →Digest-Level Clinical Commentary
These digest items reflect the fragmented landscape I navigate as a cannabis medicine practitioner: skeptical media coverage of certain therapeutic claims exists alongside emerging evidence for specific cannabinoid profiles and terpenes, while broader policy shifts toward psychedelic-assisted therapies suggest institutional willingness to explore plant-based medicine that remains absent for cannabis in many jurisdictions. The juxtaposition of legitimate medical research conversations with criminal enforcement highlights how legal and regulatory inconsistencies continue to complicate my ability to counsel patients on evidence-based cannabis use while many remain criminalized for possession. Moving forward, cannabis medicine will depend on rigorous clinical trials that distinguish between genuine therapeutic applications and unfounded claims, rather than on popular sentiment or media narratives that conflate medical use with recreational availability or criminal justice concerns.
These items reflect several concurrent developments in cannabis policy and research: the ongoing clinical evaluation of cannabis efficacy for specific medical conditions, continued consumer interest in cannabinoid products, emerging state-level psychedelic therapy initiatives, and persistent legal enforcement challenges. The mixed evidence base for medical cannabis applications, combined with expanding therapeutic research and uneven legal frameworks across jurisdictions, continues to create complexity for clinical practice and patient access. These trends suggest that standardized clinical guidance and further research remain necessary to establish clear therapeutic parameters and inform consistent policy approaches.
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it: